Holen Sie sich die Stockscreener-App
1.68
6.67%
-0.12
Finanzdaten der Pyxis Oncology Inc-Aktie (PYXS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
6.69%
25.99
|
24.36 | - | 23.46 | 22.57 |
| Operating Income/Loss |
6.69%
-25.99
|
-24.36 | -18.30 | -23.46 | -19.75 |
| Nonoperating Income/Loss |
40.81%
0.644
|
1.088 | 1.292 | 1.458 | 1.679 |
| Income/Loss From Continuing Operations Before Tax |
-25.35
|
- | -17.00 | -22.00 | -18.07 |
| Income Tax Expense/Benefit |
-
|
- | 1.103 | - | 0.283 |
| Net Income/Loss |
8.91%
-25.35
|
-23.27 | -18.11 | -22.00 | -18.35 |
| Basic Average Shares |
0.82%
63.99
|
63.47 | - | 62.56 | 61.92 |
| Diluted Average Shares |
0.82%
63.99
|
63.47 | - | 62.56 | 61.92 |
| Basic Earnings Per Share |
8.11%
-0.40
|
-0.37 | - | -0.35 | -0.30 |
| Diluted Earnings Per Share |
8.11%
-0.40
|
-0.37 | - | -0.35 | -0.30 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):